Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Some skin diseases and their treatments can negatively affect male fertility.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Mutations in certain receptors can cause diseases and offer new treatment options.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.